Managing Partner
Hadean VenturesCheck size: Hadean Ventures does not publish a standard current check-size range on its official website.
Ingrid Teigland Akay invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.
Strong science, clear clinical need, defensible intellectual property and teams able to translate research into valuable healthcare products.
Companies outside life science and healthcare, or without credible scientific and clinical foundations, are outside the stated focus.
Explain the science, unmet need, evidence, regulatory and clinical plan, intellectual-property position and the value-inflection milestone.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Ingrid Teigland Akay is a current Managing Partner at Hadean Ventures, according to the firm's official roster. No additional biography is inferred where the firm does not publish one.